Asthma Management Updates: A focus on long-acting muscarinic antagonists and intermittent inhaled corticosteroid dosing

Handouts
Quiz
Register

In this knowledge-based continuing pharmacy education activity Diana Sobieraj, PharmD, BCPS discusses asthma management updates.

Target Audience:

Pharmacists interested in asthma management.

This activity is not accredited for technicians

Learning objectives:

At the conclusion of the activity, pharmacists will be able to:

  • Explain the efficacy of LAMA and intermittent ICS on health outcomes associated with asthma
  • Recognize the asthma “step” in which LAMA or intermittent ICS therapy may be appropriate
  • Describe key counseling points for the Respimat delivery device

Activity Faculty

Diana Sobieraj, PharmD, BCPS
Assistant Clinical Professor
Department of Pharmacy Practice
University of Connecticut School of Pharmacy
Storrs, CT

Faculty Disclosure:

In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

Diana Sobieraj, PharmD, BCPS

  • I have been contracted with AHRQ through the EPC program, including sponsorship through the NHLBI
  • I have a current contract with AHRQ through the EPC program
  • I have been funded through grants from Merck, Pfizer, The Intersocietal Accreditation Commission and The American Pharmacists Association
  • I will be speaking of off label indications in my presentation

Program Fees:

Click on the registration link to register for this activity. The cost is $15.00.

Grant Funding:

This activity has no grant funding associated with it.

ACPE logoThe University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hour (0.1 CEU) will be awarded to pharmacists who view the presentation, pass the learning assessment with a grade of 70% or better and complete an evaluation. (ACPE #0009-0000-17-085-H01-P) Credits will  be electronically submitted to CPE Monitor within 72 hours of completing the activity.

Initial release date: December 19, 2017
Planned expiration date: December 15, 2020

Disclaimer:
The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.